ALTHOUGH the first case of pheochromocytoma associated with thyroid carcinoma was reported in 1932 1 it was not until 1952 that this combination of neoplasms was mentioned as occurring with unusual ...

The First International Symposium on Pheochromocytoma, held in October 2005, included discussions about developments concerning these rare catecholamine-producing tumors. Recommendations were made ...

MYOCARDIAL lesions have been described in patients who had received catecholamines for prolonged periods before death, 1–4 and similar lesions have been produced in the myocardium of laboratory ...

Ahead of Rare Disease Day, here is what you need to know about pheochromocytoma and paraganglioma, two rare types of tumors. Ahead of Rare Disease Day, here is what you need to know about two rare ...

These tumors can form spontaneously, for no known reason, or they may develop because of a faulty gene (mutation). Pheochromocytomas and paragangliomas are usually benign (noncancerous), but they can ...

Please provide your email address to receive an email when new articles are posted on . People with metastatic pheochromocytomas and paragangliomas should be closely monitored and undergo routine ...

Welireg is the first FDA-approved oral therapy for PPGL, based on the LITESPARK-015 trial results. The trial showed a 26% overall response rate, with responses lasting a median of 20.4 months. Common ...

Nat Clin Pract Endocrinol Metab. 2007;3(2):92-102. Two further related recommendations arose from the discussion session on biochemical diagnosis: first, reference intervals for plasma and urinary ...